Log In
BCIQ
Print this Print this
 

vocimagene amiretrorepvec/extended release flucytosine (Toca 511/Toca FC)

  Manage Alerts
Collapse Summary General Information
Company Tocagen Inc.
DescriptionRegimen of Toca 511, a retroviral replicating vector that delivers the cytosine deaminase gene, followed by Toca FC, which is extended-release flucytosine, an oral antifungal
Molecular Target Cytosine deaminase (CD)
Mechanism of ActionImmunotherapy
Therapeutic ModalityGene therapy: Viral vector

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/06/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today